Login / Signup

T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells.

Curtis McMurtreyMelanie J HarriffGwendolyn M SwarbrickAmanda DuncanMeghan CanslerMegan NullWilfried BardetKenneth W JacksonDeborah A LewinsohnWilliam HildebrandDavid M Lewinsohn
Published in: PloS one (2017)
HLA-E is a non-conventional MHC Class I molecule that has been recently demonstrated to present pathogen-derived ligands, resulting in the TCR-dependent activation of αβ CD8+ T cells. The goal of this study was to characterize the ligandome displayed by HLA-E following infection with Mycobacterium tuberculosis (Mtb) using an in-depth mass spectrometry approach. Here we identified 28 Mtb ligands derived from 13 different source proteins, including the Esx family of proteins. When tested for activity with CD8+ T cells isolated from sixteen donors, nine of the ligands elicited an IFN-γ response from at least one donor, with fourteen of 16 donors responding to the Rv0634A19-29 peptide. Further evaluation of this immunodominant peptide response confirmed HLA-E restriction and the presence of Rv0634A19-29-reactive CD8+ T cells in the peripheral blood of human donors. The identification of an Mtb HLA-E ligand that is commonly recognized may provide a target for a non-traditional vaccine strategy.
Keyphrases